1. Home
  2. STRO vs CIX Comparison

STRO vs CIX Comparison

Compare STRO & CIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • CIX
  • Stock Information
  • Founded
  • STRO 2003
  • CIX 1993
  • Country
  • STRO United States
  • CIX United States
  • Employees
  • STRO N/A
  • CIX N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • CIX Industrial Machinery/Components
  • Sector
  • STRO Health Care
  • CIX Consumer Discretionary
  • Exchange
  • STRO Nasdaq
  • CIX Nasdaq
  • Market Cap
  • STRO 172.8M
  • CIX 411.4M
  • IPO Year
  • STRO 2018
  • CIX 1998
  • Fundamental
  • Price
  • STRO $1.72
  • CIX $25.14
  • Analyst Decision
  • STRO Strong Buy
  • CIX
  • Analyst Count
  • STRO 7
  • CIX 0
  • Target Price
  • STRO $12.14
  • CIX N/A
  • AVG Volume (30 Days)
  • STRO 1.1M
  • CIX 12.3K
  • Earning Date
  • STRO 11-13-2024
  • CIX 02-26-2025
  • Dividend Yield
  • STRO N/A
  • CIX 5.01%
  • EPS Growth
  • STRO N/A
  • CIX N/A
  • EPS
  • STRO N/A
  • CIX 1.52
  • Revenue
  • STRO $160,955,000.00
  • CIX $150,690,000.00
  • Revenue This Year
  • STRO N/A
  • CIX N/A
  • Revenue Next Year
  • STRO N/A
  • CIX N/A
  • P/E Ratio
  • STRO N/A
  • CIX $15.70
  • Revenue Growth
  • STRO 230.90
  • CIX N/A
  • 52 Week Low
  • STRO $1.67
  • CIX $20.60
  • 52 Week High
  • STRO $6.13
  • CIX $39.91
  • Technical
  • Relative Strength Index (RSI)
  • STRO 29.77
  • CIX 42.99
  • Support Level
  • STRO $1.80
  • CIX $25.19
  • Resistance Level
  • STRO $2.15
  • CIX $27.00
  • Average True Range (ATR)
  • STRO 0.13
  • CIX 1.16
  • MACD
  • STRO 0.03
  • CIX -0.24
  • Stochastic Oscillator
  • STRO 10.42
  • CIX 25.11

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

Share on Social Networks: